The expression of VISTA on CD4(+) T cells is associated with poor prognosis and immune status in non-small cell lung cancer patients

V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel negative immune checkpoint considered to be relevant to immunotherapy resistance and a potential target for immunotherapy. In this study, we investigated the relevance of VISTA expression on CD4(+) T cells and clinical progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shengyao, Qin, Liya, Wang, Xinling, Wang, Weiyu, Li, Jinfeng, Wang, Huaijie, Li, Hanyue, Cai, Xiaoshan, Yang, Yang, Qu, Meihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519165/
https://www.ncbi.nlm.nih.gov/pubmed/35122478
http://dx.doi.org/10.17305/bjbms.2021.6531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519165/
https://www.ncbi.nlm.nih.gov/pubmed/35122478
http://dx.doi.org/10.17305/bjbms.2021.6531

Ejemplares similares